Follow
Humam Kadara
Humam Kadara
Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic …
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
7792015
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ...
Nature medicine 27 (3), 504-514, 2021
4342021
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
3762020
Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells
AK Pathak, M Bhutani, AS Nair, KS Ahn, A Chakraborty, H Kadara, ...
Molecular cancer research 5 (9), 943-955, 2007
3052007
IL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras–mutant lung cancer
MS Caetano, H Zhang, AM Cumpian, L Gong, N Unver, EJ Ostrin, S Daliri, ...
Cancer research 76 (11), 3189-3199, 2016
1952016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
H Kadara, M Choi, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ...
Annals of Oncology 28 (1), 75-82, 2017
1942017
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
T Cascone, MH Herynk, L Xu, Z Du, H Kadara, MB Nilsson, CJ Oborn, ...
The Journal of clinical investigation 121 (4), 1313-1328, 2011
1782011
Comprehensive T cell repertoire characterization of non-small cell lung cancer
A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ...
Nature communications 11 (1), 603, 2020
1662020
Circulating tumor cell detection technologies and clinical utility: Challenges and opportunities
Z Habli, W AlChamaa, R Saab, H Kadara, ML Khraiche
Cancers 12 (7), 1930, 2020
1632020
Ets2 mediated tumor suppressive function and met oncogene inhibition in human non–small cell lung cancer
M Kabbout, MM Garcia, J Fujimoto, DD Liu, D Woods, CW Chow, ...
Clinical cancer research 19 (13), 3383-3395, 2013
1622013
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non–small cell lung carcinoma
C Behrens, LM Solis, H Lin, P Yuan, X Tang, H Kadara, E Riquelme, ...
Clinical cancer research 19 (23), 6556-6565, 2013
1542013
High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and mutation
MI Nunez, C Behrens, DM Woods, H Lin, M Suraokar, H Kadara, ...
Journal of thoracic oncology 7 (5), 833-840, 2012
1512012
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung
P Yuan, H Kadara, C Behrens, X Tang, D Woods, LM Solis, J Huang, ...
PloS one 5 (2), e9112, 2010
1442010
Image analysis–based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non–small cell lung carcinoma patients
ER Parra, C Behrens, J Rodriguez-Canales, H Lin, B Mino, J Blando, ...
Clinical Cancer Research 22 (24), 6278-6289, 2016
1432016
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov …
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
External Resources Crossref (DOI), 2012
1432012
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome
LM Solis, C Behrens, MG Raso, HY Lin, H Kadara, P Yuan, H Galindo, ...
Cancer 118 (11), 2889-2899, 2012
1282012
Pulmonary adenocarcinoma: a renewed entity in 2011
H Kadara, M Kabbout, II Wistuba
Respirology 17 (1), 50-65, 2012
1112012
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer
Y Kudo, C Haymaker, J Zhang, A Reuben, DY Duose, J Fujimoto, ...
Annals of Oncology 30 (9), 1521-1530, 2019
1072019
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
X Hu, J Fujimoto, L Ying, J Fukuoka, K Ashizawa, W Sun, A Reuben, ...
Nature communications 10 (1), 2978, 2019
1032019
Early events in the molecular pathogenesis of lung cancer
H Kadara, P Scheet, II Wistuba, AE Spira
Cancer prevention research 9 (7), 518-527, 2016
1032016
The system can't perform the operation now. Try again later.
Articles 1–20